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Abstract
Purinergic receptors, which bind adenosine 5
0-triphosphate (ATP), are expressed on human cutaneous keratinocytes and
in squamous cell carcinomas. Studies on normal human epidermis and primary keratinocyte cultures have suggested that
P2X5 receptors are likely to be involved in keratinocyte differentiation and P2X7 receptors are likely to be part of the
machinery of end stage terminal differentiation/apoptosis of keratinocytes. P2X7 receptor agonists can significantly
reduce primary keratinocyte cell numbers in culture. Human papillomaviruses are increasingly recognised as important
human carcinogens in the development of non-melanoma skin cancers. In our study, immunohistochemical analysis for
P2X5 and P2X7 receptors was performed on paraffin sections of normal human skin, warts, raft cultures of normal human
keratinocytes and raft cultures of CIN 612 cells, a model of keratinocytes infected with human papillomavirus type 31. In
warts there was up-regulation of the expression of P2X5 receptors. A similar pattern was seen in the CIN 612 raft cultures.
Both P2X5 and P2X7 receptors were found in the nuclei of koilocytes, abnormal keratinocytes characteristic of human
papillomavirus infection. P2X5 and P2X7 receptors may provide a new focus for therapeutic research into treatments for
warts because these receptors can induce cell differentiation and cell death.
Abbreviations: ADP –adenosine 5
0-diphosphate; ATP–adenosine 5
0-triphosphate; BCC–basal cell carcinoma; DAB–
diaminobenzidine; GFP–green fluorescent protein; HPV–human papillomavirus; NHEK–normal human epidermal
keratinocytes; SCC–squamous cell carcinoma
Introduction
Non-melanoma skin cancer is the most frequently occur-
ring malignancy worldwide in the Caucasian population
[1]. Ultraviolet radiation is the major environmental factor
in the pathogenesis of basal cell carcinomas (BCC) and
squamous cell carcinomas (SCC), which tend to occur in
sun-exposed sites [2]. The ratio of BCCs to SCCs is 5:1 in
immunocompetent populations, whereas in immunosup-
pressed patients the ratio is reversed, with the risk of
developing a SCC up to 250 times greater and the risk of
developing a BCC 10 times greater than that in the general
population [3]. The difference in incidence of these tu-
mours in immunocompromised patients is thought to be
due to the involvement of papillomaviruses. The associa-
tion between warts and skin cancer was first noted in renal
transplant recipients [4]. Human papillomaviruses (HPVs)
are small double-stranded DNA viruses that are widespread
in the human population. They are strictly epitheliotropic
and infect only cutaneous and mucosal skin sites. Over 120
different HPV types have been identified, of which 80 have
been characterised in full [3].
There is increasing evidence that purinergic signalling
can have long-term, trophic effects in cell growth, pro-
liferation, differentiation and death [5, 6]. Purinergic
receptors are classified into two groups: P1 receptors are
selective for adenosine and P2 receptors are selective for
adenosine 5
0-triphosphate (ATP) and adenosine 5
0-diphos-
phate (ADP), which act as extracellular signalling mole-
cules [7]. P2 receptors are sub-divided into P2X and P2Y
receptor families [8, 9]. P2X receptors are ligand-gated ion
channels, and are activated by extracellular ATP to elicit a
flow of cations (Na
+,K
+ and Ca
2+) across the plasma
membrane. Seven subtypes of P2X receptors are recog-
nised [10]. In contrast, P2Y receptors are G protein-
coupled and eight subtypes of P2Y receptors have been
described [11]. P2X receptors are largely viewed as
mediators of short term, fast intercellular communication.
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mediate trophic effects. P2X5 receptors have been impli-
cated in the regulation of osteoblastic differentiation and
proliferation [12], and triggering the differentiation of
skeletal muscle satellite cells [13]. P2X7 receptors have
been shown to mediate ATP-induced apoptosis [14, 15].
ATP is likely to be an important local messenger in the
epidermis. Both P2X5 and P2X7 receptors are expressed on
adult rat cutaneous keratinocytes and functional roles in the
regulation of cell turnover have been proposed [16].
Studies on adult human epidermis and primary keratino-
cyte cultures [17] have suggested that P2X5 receptors are
likely to be involved in early keratinocyte differentiation
and P2X7 receptors are likely to be part of the machinery
of end stage terminal differentiation/apoptosis of keratino-
cytes. P2X5 and P2X7 receptors have altered expression in
both BCCs and in SCCs and functional experiments using
a cutaneous squamous cell carcinoma cell line, A431, have
shown that purinergic receptors could in future provide
novel therapeutic targets in non-melanoma skin cancers
[18]. P2X5 receptors are also involved in the differentiation
of human fetal epidermis [19] and in rat wound healing
[20].
This study compares the distribution of P2X5 and P2X7
receptors in normal human skin, with that in human warts.
Vegetative reproduction of HPV particles can only take
place in highly differentiated keratinocytes. This has made
it difficult to study the effects of HPV in vitro. We studied
the distribution of P2X5 and P2X7 receptors in HPV
infected keratinocytes grown as an organotypic raft culture,
where the cells are permitted to differentiate and stratify.
These receptors may be a useful target for further research
into both HPV and the carcinogenesis of cutaneous SCCs
using organotypic raft cultures of HPV infected keratino-
cytes as a research tool.
Materials and methods
Tissues
Paraffin sections of samples of normal skin, human warts,
normal human epidermal keratinocyte (NHEK) raft cul-
tures and CIN 612 (HPV 31 infected cell line) raft cultures
were stained for P2X5 and P2X7 receptors. Ethics Com-
mittee Approval was obtained to harvest human skin
samples. Paraffin blocks of warts, NHEK raft cultures
and CIN 612 raft cultures were prepared by Roche
Discovery, Welwyn. Six samples of each were used in
the study, with at least four sections of each sample. P2X5
and P2X7 receptors were examined because they are
involved in early keratinocyte differentiation and terminal
keratinocyte differentiation/apoptosis respectively.
Raft cultures of differentiated HPV-infected keratinocytes
The method for raft culture of keratinocytes has already
been described [21]. Briefly, primary human foreskin
keratinocytes (NHEKs) were obtained from Clonetics
(San Diego, USA), the CIN 612 cell line was established
from a CIN I biopsy and contained HPV31b DNA.
Epithelial cells were seeded onto collagen matrices con-
taining J2 3T3 fibroblast feeders. When the epithelial cells
had grown to confluence, collagen matrices were lifted
onto stainless steel grids and the cells were fed by diffusion
from under the matrix. The cells were allowed to stratify
and differentiate at the airYliquid interface over a 16-day
period. Raft cultures were then harvested, fixed in 4%
paraformaldehyde and embedded in paraffin.
Antibodies
The immunogens used for production of polyclonal P2X5
and P2X7 antibodies were synthetic peptides corresponding
to 15 receptor-type-specific amino acids in the intracellular
C-termini of the cloned rat and human P2X receptors, as
previously described [16, 22]. P2X5 and P2X7 antibodies
were kept frozen at a stock concentration of 1 mg/ml and
used at a dilution of 1:200.
Immunohistochemical method for paraffin sections
The method below was an adaptation of the routine method
used for immunohistochemistry in paraffin sections at
RAFT and was developed by Elizabeth Clayton, Histology
Department, RAFT. The method is described in detail in
[18]. Briefly, Microwave antigen retrieval was used for the
visualization of both P2X5 and P2X7 receptors in 4 mm
paraffin sections. P2X5 receptors were demonstrated via
tyramide amplification and a diaminobenzidine (DAB)
final substrate system, so that receptors were stained
brown. P2X7 receptors were demonstrated using a routine
Streptavidin Alkaline Phosphatase method and a Vector
Red final substrate system (Vector Laboratories, Peter-
borough, UK), so that receptors were stained pink. Nuclei
were counterstained blue with Harris
0s haematoxylin.
Control experiments were carried out with the primary
antibody omitted from the staining procedure. From
previous work in frozen sections, there was no staining in
both the no primary controls and upon pre-absorption of
the primary antibody with the corresponding peptide [17].
Photography
The results were analysed using a Zeiss Axioplan high
definition light microscope (Oberkochen, Germany)
mounted with a Leica DC 200 digital camera (Heerbrugg,
Switzerland).
Results
P2X5 and P2X7 receptors in paraffin sections
of normal human skin
P2X5 immunoreactivity was present mainly in the viable
cell layers of normal human skin (Figure 1a), where the
510 A.V.H. Greig et al.staining was confined largely to the cell membranes and
the cytoplasm in epidermal keratinocytes, with occasional
nuclear staining. P2X7 immunoreactivity was present in the
epidermis of all normal skin samples, and was associated
with cells and cell fragments in the stratum corneum
(Figure 1b). There was some staining of the outermost edge
of the stratum corneum with the P2X5 receptor antibody,
which was only slightly reduced in the no primary antibody
control (Figure 1c), and therefore non-specific staining.
There was no staining in the no primary control for the
P2X7 receptor antibody (Figure 1d).
P2X5 and P2X7 receptors in paraffin sections
of human warts
In warts, there was marked hyperkeratosis and paraker-
atosis within the stratum corneum. P2X5 receptors were
present in nucleated keratinocytes in areas of parakeratosis,
but not within the hyperkeratotic areas of the stratum
corneum (Figure 2a). In contrast, P2X7 receptors were
found in hyperkeratotic areas of the stratum corneum but
not in parakeratotic areas of the wart (Figure 2b). P2X5
immunoreactivity was present in the majority of wart
keratinocytes (Figure 2c), but few cells in the basal layer
were positive, with most of the positively stained cells in
the suprabasal layers. P2X7 receptors were found in the
nuclei of suprabasal cells (Figure 2d). There was a
prominent granular layer in the wart with koilocytes.
Koilocytes are the characteristic cytological feature of
HPV infection. Koilocytes are keratinocytes with pyknotic,
deeply blue nuclei surrounded by a halo and clear
cytoplasm with a paucity of keratohyaline granules. They
usually indicate the presence of human papilloma virus.
Both P2X5 and P2X7 receptors were found in the nuclei of
koilocytes (Figure 2c,d). There was a band of heavy
staining of the outermost edge of the stratum corneum
with the P2X5 receptor antibody (Figure 2a), which was
still present in the no primary antibody control (Figure 2e),
and therefore was non-specific staining. There was no
staining in the no primary control for the P2X7 receptor
antibody.
P2X5 and P2X7 receptors in paraffin sections of raft
cultures of normal human keratinocytes and of CIN 612
(HPV 31) cells
P2X5 immunoreactivity was present throughout all the
layers of the raft cultures of normal human foreskin
keratinocytes (Figure 3a), where the staining was confined
largely to the cell membranes and the cytoplasm. P2X7
immunoreactivity was present in the raft cultures of
normal human foreskin keratinocytes, staining weakly
within the uppermost layer (rudimentary stratum corneum)
(Figure 3b). The P2X7 receptor staining was not as strik-
ingly positive as with the paraffin section of normal skin
(Figure 1b).
P2X5 immunoreactivity was present in the CIN 612
(HPV 31) raft keratinocytes (Figure 3c), where the staining
was seen within all layers of the raft. P2X7 immunor-
eactivity was present in the CIN 612 raft (Figure 3d) and
was associated with the cell cytoplasm in the HPV infected
cells. At higher power, the uppermost layers are highly
disorganised, with nucleated cells at the surface of the raft
(Figure 3e,f). There was positive staining in the cytoplasm
of mitotic cells within the raft for both P2X5 (Figure 3e)
and P2X7 (Figure 3f) receptors.
Figure 1. Expression of P2X5 and P2X7 receptors in paraffin sections of normal human skin. Nuclei were counterstained blue with haematoxylin. a In
normal skin, P2X5 immunoreactivity (brown) was found in basal keratinocytes (B) (although this was not easy to distinguish from melanin), and in the
stratum spinosum (SS), and in very few cells in the stratum granulosum (SG). P2X5 receptor staining was absent from the stratum corneum (SC), apart
from at the outer edge. P2X5 receptor staining was confined largely to the cell membranes in the basal layer, and found in the cytoplasm, and
occasionally in the nucleus in both basal and suprabasal keratinocytes. Scale bar. 25 mm. b P2X7 immunoreactivity (pink) was present in the epidermis
of all normal skin samples, and was associated with cells and cell fragments (arrow) in the stratum corneum (SC). Note the brown melanin in the basal
layer (B). Scale bar,2 5mm. c There was residual staining of the outermost edge of the stratum corneum (arrow) with the P2X5 receptor antibody no
primary control, and therefore this was non-specific staining. Note the brown melanin in the basal layer (B). Scale bar,2 5mm. d There was no staining
in the no primary control for the P2X7 receptor antibody Scale bar. 25 mm.
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This paper adds extra understanding of the role of P2X5
and P2X7 receptors in keratinocytes differentiating under
abnormal circumstances, for example during human papil-
loma virus infection. Human papilloma viruses are increas-
ingly recognised as an important human carcinogen and
have been implicated in non-melanoma skin cancers [23,
24]. The association between skin warts and skin cancer
was first noted in renal transplant recipients [4] who have a
marked increase in susceptibility to both viral warts and
non-melanoma skin cancer. Clinical and histological
features of transplant SCCs indirectly support the pro-
gression of viral warts through increasingly dysplastic
squamous lesions to invasive SCCs [25]. P2X5 and P2X7
receptors have altered expression in both BCCs and in
SCCs [18]. We examined the expression of these receptors
in human papilloma virus infected keratinocytes with the
long-term aim of establishing whether they may also have
a role as a potential therapeutic target.
Figure 2. Expression of P2X5 and P2X7 receptors in paraffin sections of human warts. Nuclei were counterstained blue with haematoxylin. a Low
power view of P2X5 immunoreactivity (brown) in the wart. P2X5 receptors were present within the keratinocytes of the wart. There was marked
hyperkeratosis (H), which was negative for P2X5 receptors, although areas of parakeratosis were positive (arrow). At the outer edge of the stratum
corneum there was a band of heavy staining (asterisk). P2X5 receptors were also found in the inflammatory cell infiltrate (I) above the stratum corneum
(SC). There was a prominent granular layer (SG), within which cells (koilocytes) showed typical cytoplasmic vacuolation (arrowheads). Scale bar. 100
mm. b Low power view of P2X7 immunoreactivity (pink) in the wart. P2X7 receptors were strongly present within the hyperkeratotic (H) areas of the
stratum corneum (SC), but not in areas of parakeratosis (arrow). P2X7 receptors were weakly present in the wart keratinocytes, and mainly found in the
nucleus. P2X7 receptors were also weakly found in the inflammatory cell infiltrate (I) above the stratum corneum. Scale bar, 100 mm. c High power
view of P2X5 immunoreactivity (brown) in wart keratinocytes. There were a few positive cells in the basal layer (B), but most of the positively stained
cells were in the suprabasal layers. Koilocytes showed P2X5 receptor staining in the nucleus (arrowheads). Scale bar,5 0mm. d P2X7 immunoreactivity
(pink) was present in the suprabasal layers of the wart, in either large, flat nuclei with an obvious nuclear membrane (arrow), or in koilocytes, where the
receptor was prominent in shrunken, pynotic nuclei, (arrowheads). P2X7 receptors were not found in the basal layer (B) of the wart. Scale bar,5 0mm. e
There was residual staining of the outermost edge of the stratum corneum (asterisk) with the P2X5 receptor antibody no primary control, and therefore
this was non-specific staining. Scale bar, 100 mm. f There was no staining in keratinocytes of the wart with the P2X5 receptor antibody no primary
control. There was some melanin in the basal layer (B) of the wart. Scale bar,5 0mm.
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expression were examined within human papilloma virus
infected differentiated keratinocytes in both warts and in a
model system. The organotypic raft model was chosen
because it would allow an in vitro model of both the nor-
mal epidermis and of a wart that could later be compared
and manipulated with drugs. This model allows keratino-
cytes to differentiate and stratify at an air fluid interface.
Since human papilloma virus replication tends to take
place in differentiated keratinocytes, this model has the
advantage of allowing us to study differentiated cells,
which would be much harder to do with monolayer
keratinocyte culture systems. Previous work has proposed
that P2X5 receptors are involved in early differentiation of
keratinocytes and that P2X7 receptors are involved in the
terminal differentiation of keratinocytes [17]. The draw
back of the organotypic raft culture model is that the
keratinocytes only differentiate to form a rudimentary
stratum corneum, making it harder to study the expression
of P2X7 receptors.
In this study, we obtained the first direct evidence for the
expression of P2X5 and P2X7 receptors in human warts,
using immunohistochemistry. Studies on normal human
epidermis and functional studies on primary keratinocyte
cultures [17] have suggested that P2X5 receptors are likely
to be involved in keratinocyte differentiation and P2X7
receptors are likely to be part of the machinery of end stage
terminal differentiation of keratinocytes. 2
0- and 3
0-0-(4-
BenzoylYbenzoyl) ATP, a potent P2X7 receptor agonist,
causes a significant decrease in cell number via a direct
effect on P2X7 receptors [17], which are also involved in
mediating apoptosis [26, 27].
In normal skin, P2X5 receptors were found in the basal
layer, stratum spinosum and weakly in the stratum
granulosum, with occasional nuclear staining. There was
little or no P2X5 receptor staining in the stratum corneum,
apart from some staining artefact. In the raft cultures of
normal human foreskin keratinocytes, P2X5 receptors were
found throughout all layers, from the basal layer to the
most differentiated layer. Warts arise because human
papillomaviruses infect the basal keratinocyte of the
epidermis, presumably through disruptions of the skin or
mucosal surface [28]. The virus remains latent in basal
cells as a circular episome. As keratinocytes differentiate
and migrate to the surface, the virus is triggered to undergo
replication and maturation. Hybridisation studies in situ of
Figure 3. Expression of P2X5 and P2X7 receptors in paraffin sections of raft cultures of normal human keratinocytes and of CIN 612 (HPV 31) cells.
Nuclei were counterstained blue with haematoxylin. a P2X5 immunoreactivity (brown) was present throughout all layers of the raft cultures of normal
human foreskin keratinocytes, where the staining was confined largely to the cell membranes and the cytoplasm. The raft culture was supported on a
collagen matrix (C). Scale bar. 25 mm. b P2X7 immunoreactivity (pink) was present in the raft cultures of normal human foreskin keratinocytes, staining
weakly within the uppermost layer (arrows). Scale bar. 25 mm. c P2X5 immunoreactivity (brown) was present in the CIN 612 (HPV 31) raft
keratinocytes, staining all layers of the raft. Scale bar. 50 mm. d P2X7 immunoreactivity (pink) was present in the CIN 612 raft and was associated with
the cell cytoplasm and nucleus (arrow). Scale bar. 50 mm. e, f High power views of CIN 612 (HPV 31) raft cultures: the uppermost layers are highly
disorganised, with nucleated cells at the surface of the raft (arrows). There was also positive staining in the cytoplasm of mitotic cells (double arrows)
within the raft for both e P2X5 receptors (brown) Scale bar 25 mm. and f P2X7 receptors (pink). Scale bar. 25 mm.
P2 receptors in warts and CIN-612 raft cultures 513HPV lesions have shown that viral DNA synthesis occurs
in the skin in the superficial stratum spinosum and full
virus assembly with capsid production occurs in the
stratum granulosum. In warts there is a prominent granular
cell layer, within which there are vacuolated cells called
koilocytes, characteristic of HPV infection. The process of
virus replication alters the character of the epidermis,
resulting in cutaneous or mucosal excrescences known as
warts. In warts, P2X5 receptor staining was increased
compared to that in normal skin. There were few P2X5
receptor positive cells in the basal layer, most of the
positively stained cells being in the suprabasal layers.
HPV infections are classified into cutaneous, cutaneous
involved in epidermodysplasia verruciformis, cutaneous
and mucosal, and mucosal of low and high risk [29]. HPVs
are linked with cervical cancer and SCC of the anus [30],
which are associated with high risk genital HPV types 16,
18, 31, 33 and the low risk genital HPV types 6 and 11
[31]. Examination of immunostaining of P2X5 and P2X7
receptors on paraffin sections of cervical epithelium have
shown that P2X5 receptors are expressed in the suprabasal,
differentiated layers of the epithelium, but not in the basal
layer. P2X7 receptor immunostaining was weakly present
in the terminally differentiated cells of this non-keratinised
epithelium. So these receptors are expressed in cervical
cells. In the CIN 612 (HPV 31) raft cultures, P2X5 recep-
tors were found in all cell layers and the level of staining
was more intense than in the normal keratinocyte raft
cultures.
Hyperproliferation is a feature of warts. Immunohisto-
chemical labelling of frozen sections of other hyperprolifer-
ative lesions e.g. psoriasis, with P2X5 receptor antibodies
has shown increased expression of the receptor in hyper-
proliferative areas of the epidermis. In psoriasis, rapid
proliferation of keratinocytes leads to the production of
immature keratin at the surface that has not completed
its terminal differentiation process. This shows as silvery
scaly psoriatic plaques on the skin surface. The receptor
is again more prominent in suprabasal layers of the epi-
dermis in differentiating and differentiated keratinocytes.
This would suggest that this receptor is part of the differ-
entiation process rather than part of a proliferative pro-
cess. Interestingly a high prevalence of HPV DNA has
also been found in psoriasis [32, 33].
P2X5 receptors have also been implicated in the reg-
ulation of osteoblastic differentiation and proliferation
[12], and triggering the differentiation of skeletal muscle
satellite cells [13]. In fetal rat skeletal muscle, P2X5 re-
ceptors are sequentially expressed during development
[34]. P2X5 receptors are also involved in the differentiation
of the human fetal epidermis [19] and play a role in wound
healing in the rat epidermis [20].
In normal human skin, P2X7 receptor immunoreactivity
was solely associated with cells and cell fragments within
the stratum corneum [17]. In the raft cultures P2X7
receptor staining was very weak compared to normal skin.
This may be due to the phenomenon of incomplete
differentiation that occurs in raft cultures, thought to be
associated with the presence of retinoids in the medium
[35]. In warts, P2X7 immunoreactivity was associated with
hyperkeratotic areas of the stratum corneum, as well as in
nuclei of koilocytes in the suprabasal layers. The nuclei
that were positive for P2X7 receptors were not normal:
nuclei were shrunken, with much more intense, pink P2X7
receptor staining. In the CIN 612 raft cultures, P2X7
immunoreactivity was positive in both the cell cytoplasm
and in the nucleus of HPV infected cells. The P2X7
receptor is a bifunctional molecule that can be triggered to
act as a channel, permeable to small cations, or on pro-
longed stimulation form a cytolytic pore permeable to large
hydrophilic molecules up to 900 Da [36]. The opening of
this pore results in the increase in intracellular cytosolic
free calcium ions and the induction of cell death [26, 27]. It
is possible that the presence of P2X7 receptors in the
nucleus of HPV infected cells indicates a severe disruption
of the cellular machinery. It might be possible to use P2X7
receptor agonists to trigger apoptosis in these virally
infected cells. P2X7 receptors are also found on dendritic
cells, macrophages and microglial cells, where extracellu-
lar ATP can trigger apoptosis via these receptors and there
is increasing evidence that this process is dependent on the
caspase signalling cascade [14, 37].
In summary, P2X5 and P2X7 receptors may provide a
useful focus for more research into new treatment
modalities for warts and SCCs because these receptors
can induce cell differentiation as well as cell death. Vege-
tative reproduction of HPV particles can only take place in
highly differentiated keratinocytes. Raft cultures of both
normal human keratinocytes and HPV infected cells could
prove to be a useful tool for further study of these receptors
in vitro.
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